imperatorin has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Czarnocki, Z; Granica, S; Jarończyk, M; Kiss, AK; Maurin, JK; Mazurek, AP | 1 |
| Biala, G; Boguszewska-Czubara, A; Budzynska, B; Kruk-Slomka, M; Michalak, A; Musik, I; Skalicka-Wozniak, K | 1 |
2 other study(ies) available for imperatorin and Alzheimer Disease
| Article | Year |
|---|---|
Synthesis of imperatorin analogs and their evaluation as acetylcholinesterase and butyrylcholinesterase inhibitors.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Binding Sites; Butyrylcholinesterase; Cholinesterase Inhibitors; Furocoumarins; Galantamine; Molecular Docking Simulation; Structure-Activity Relationship | 2013 |
Effects of imperatorin on scopolamine-induced cognitive impairment and oxidative stress in mice.
Topics: Alzheimer Disease; Animals; Brain; Cognition; Disease Models, Animal; Furocoumarins; Male; Memory; Memory Disorders; Mice; Oxidative Stress; Plant Extracts; Scopolamine | 2015 |